Valiant Laboratories Limited IPO
Valiant Laboratories Limited was a mainboard IPO in the Pharmaceuticals sector, offered at ₹133–₹140 per share to raise ₹46 crore. The issue was subscribed 29.76× overall (QIBs 20.83×, NIIs 73.64×, retail 16.06×). It listed on 6 Oct 2023 at ₹162 and closed its first day at ₹170, a listing gain of +21.6% versus the ₹140 issue price. It now trades around ₹128 (-8.3% versus the issue price).
Frequently asked questions
- How many times was the Valiant Laboratories Limited IPO subscribed?
- The Valiant Laboratories Limited IPO was subscribed 29.76× overall — 20.83× in the QIB category, 73.64× among non-institutional investors, 16.06× in retail.
- What were the Valiant Laboratories Limited IPO listing gains?
- Valiant Laboratories Limited listed on 6 Oct 2023 at ₹162, closing its first day at ₹170 — a listing gain of +21.6% versus the ₹140 issue price.
- What were the retail allotment odds for the Valiant Laboratories Limited IPO?
- Retail was subscribed 16.06×, so a single-lot application had roughly a 6.2% chance of allotment (about 1 in 16), and allotment was finalised on 2 Oct 2023.
- What was the price band and lot size of the Valiant Laboratories Limited IPO?
- The price band was ₹133–₹140 per share, with a minimum lot of 105 shares (₹14,700 at the upper band).
- Who were the registrar and lead manager for the Valiant Laboratories Limited IPO?
- Link Intime India Private Limited was the registrar, and Unistone Capital was the book-running lead manager.